Navigation Links
Dendreon Announces Webcast Presentation at Credit Suisse 2010 Health Care Conference
Date:11/5/2010

SEATTLE, Nov. 5, 2010 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the Credit Suisse 2010 Health Care Conference, Phoenix, AZ on November 11, 2010 at 1:30 p.m. ET.

The presentation will be audio webcast live and available for replay from Dendreon's website, www.dendreon.com.  If you are unable to listen to the live webcast, it will be archived on the site following the presentation. To access the replay, go to the Investor Relations section of the website.

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response in a variety of tumor types. Dendreon's first product, PROVENGE®, was approved by the FDA in April 2010. Dendreon is exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. The Company is headquartered in Seattle, Washington and is traded on the NASDAQ Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com/.


'/>"/>
SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
3. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
4. Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
5. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
6. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
7. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
8. Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
9. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
10. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
11. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... MUMBAI, India , June 19, ... Book Bureau has recently added DrugPatentWatch ... Databases. ( http://www.bharatbook.com/drugpatentwatch-tour.pdf ) ... DrugPatentWatch provides comprehensive information on pharmaceutical, ... value-added information supports the critical business ...
(Date:6/19/2013)... June 19, 2013 DST Health Solutions, LLC ... to health plans, integrated delivery systems, and health care ... Drug Management Service (MDMS) has jumped significantly. ... automate the pricing of medical prescription drug claims, MDMS ... automating their medical drug claims processes. As specialty drug ...
(Date:6/19/2013)... 2013   Life Technologies Corporation (NASDAQ: ... granting Suzhou Ribo Life Sciences (Ribo) the exclusive ... China using Life,s Invivofectamine® ... molecules in combination with Invivofectamine® Rx to create ... with high unmet medical need in the Chinese ...
Breaking Medicine Technology:Drug Patent Watch 2Drug Patent Watch 3Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4
... 2011  HeartWare International, Inc. (NASDAQ: HTWR ... miniaturized circulatory support technologies that are revolutionizing the treatment ... Godshall is scheduled to present at the 23 rd ... a.m. EST on Wednesday, November 30, 2011. The conference ...
... Inc. (NYSE: LDR), will release financial results for the ... December 6, 2011. The company will host ... at 2:00 p.m. Eastern Time. Investors may access the live ... or 480-629-9692 (international callers), or by visiting the "Investors" page ...
Cached Medicine Technology:HeartWare to Present at the 23rd Annual Piper Jaffray Health Care Conference 2Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2011 Results 2
(Date:6/20/2013)... June 20, 2013 As a key ... Navneet Tyagi has remained closely linked to ... myriad of scientific research that Tyagi has participated in, ... early onset of these severe and mysterious neurological conditions. ... medical researchers will be able to understand about the ...
(Date:6/20/2013)... 20, 2013 During a June 13 ... of the Maryland Health Benefit Exchange confirmed the existence ... many in the industry consider,” writes panel moderator Steve ... “as mythical as unicorns and leprechauns.” , “We are ... Federal Data Services Hub live,” Rebecca Pearce told attendees ...
(Date:6/20/2013)... (PRWEB) June 20, 2013 Handgiftbox.com Mobile, ... tablet and accessories, announced today the launch of ... Handgiftbox.com Mini STUDIO 16GB is a high-performance, high-quality tablet ... Mini Studio 16GB MSRP is at $256 but it ... end of June only from Handgiftbox.com.com. , The Mini ...
(Date:6/20/2013)... June 20, 2013 Emotional abuse expert ... about indentifying and confronting tactics used by emotional abusers. ... emotional abuse and not being spoken to for days, ... She experienced these behaviors and more in her ... in the marriage for 13 years because she did ...
(Date:6/20/2013)... 20, 2013 Millions of Britons are ... medical conditions because they do not brush their teeth ... Elgydium toothpaste. , Seven million Britons do not clean ... between brushes, latest data from the British Dental Health ... polled by the BDHF also admitted that they forgot ...
Breaking Medicine News(10 mins):Health News:Navneet Tyagi Supports Continued Efforts for Alzheimer Detection Procedures 2Health News:Navneet Tyagi Supports Continued Efforts for Alzheimer Detection Procedures 3Health News:Federal Data Services Hub Does Exist, AISHealth.com Blog Post Reports 2Health News:Android Tablet PC Mini Studio with Android 4.1 with 16GB is Here at $121 Only at Handgiftbox.com 2Health News:Lisa Kroulik Empowers Women to Recognize Emotional Abuse in Intimate Relationships 2Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 2Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 3
... acupuncture reduce itching, improve quality of life, study finds ... traditional Chinese medicine, including tea and acupuncture, may safely ... report finds. , Use of Erka Shizheng ... eight months greatly reduced the severity of the itchy, ...
... health care recruiting and staffing. Individuals have the choice of starting ... with an established Health Career Agents office. , ... ... now has three ways for qualified individuals to get involved in ...
... presented new NCCN Clinical Practice Guidelines in Oncology(TM) ... important updates to the NCCN Guidelines for Non-Hodgkin,s ... new NCCN Guidelines were written to distinguish Primary ... clinicians with treatment recommendations. Andrew D. Zelenetz, MD, ...
... InterMune, Inc. (Nasdaq: ITMN ) today announced ... President of InterMune, will present at the Cowen and ... March 17, 2009 at 3:10 p.m. EDT.To access a ... interested parties may log on to the investor relations ...
... As a result of the FDA expanding the Peanut Corporation of ... lla related recall to include all peanut ingredient ... Weaver Popcorn Company, Inc. has issued a precautionary voluntary recall for ... , s End (R) Chocolatey Peanut ...
... removal is another reproductive factor linked to cardiovascular trouble, ... The things that affect a woman,s reproductive health can ... shows. , Giving birth prematurely or delivering a small-for-gestational-age ... cardiovascular disease in the mother, according to two studies ...
Cached Medicine News:Health News:Health Career Agents Announces Three Options for Involvement in Health Care Recruiting and Staffing 2Health News:Health Career Agents Announces Three Options for Involvement in Health Care Recruiting and Staffing 3Health News:New NCCN Guidelines for Primary Cutaneous B-Cell Lymphoma and Updates to NCCN Guidelines for Non-Hodgkin's Lymphomas 2Health News:New NCCN Guidelines for Primary Cutaneous B-Cell Lymphoma and Updates to NCCN Guidelines for Non-Hodgkin's Lymphomas 3Health News:New NCCN Guidelines for Primary Cutaneous B-Cell Lymphoma and Updates to NCCN Guidelines for Non-Hodgkin's Lymphomas 4Health News:Weaver Popcorn Company Issues a Nationwide Precautionary Voluntary Recall of 12 oz. (340g) Trail's End(R) Chocolatey Peanut Clusters 2Health News:Preemie Delivery Tied to Later Heart Woes for Women 2Health News:Preemie Delivery Tied to Later Heart Woes for Women 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: